Foghorn Therapeutics (FHTX) Insider Trading & Ownership $4.98 -0.16 (-3.11%) (As of 12:30 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Foghorn Therapeutics (NASDAQ:FHTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage9.07%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$367,705.93 Get FHTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Foghorn Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FHTX Insider Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Foghorn Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/23/2024Carlos CostainsiderSell857$10.17$8,715.69 9/20/2024Carlos CostainsiderSell35,756$10.04$358,990.24 (Data available from 1/1/2013 forward) FHTX Insider Trading Activity - Frequently Asked Questions Who is on Foghorn Therapeutics's Insider Roster? The list of insiders at Foghorn Therapeutics includes Carlos Costa, and Samuel Agresta. Learn more on insiders at FHTX. What percentage of Foghorn Therapeutics stock is owned by insiders? 9.07% of Foghorn Therapeutics stock is owned by insiders. Learn more on FHTX's insider holdings. Which Foghorn Therapeutics insiders have been selling company stock? The following insiders have sold FHTX shares in the last 24 months: Carlos Costa ($367,705.93), and Samuel Agresta ($2,568,200.25). How much insider selling is happening at Foghorn Therapeutics? Insiders have sold a total of 347,910 Foghorn Therapeutics shares in the last 24 months for a total of $2,935,906.18 sold. Foghorn Therapeutics Key ExecutivesMr. Adrian H. B. Gottschalk (Age 48)President, CEO & Director Compensation: $784.65kDr. Steven F. Bellon Ph.D. (Age 59)Chief Scientific Officer Compensation: $572.6kDr. Alfonso Quintas Cardama M.D. (Age 53)Chief Medical Officer Compensation: $300.16kDr. Gerald R. Crabtree M.d.Founder & Member of Scientific Advisory BoardMr. Kristian Humer M.B.A. (Age 48)Chief Financial Officer Ms. Karin HellsvikVP, Corporate Affairs & Investor RelationsMr. Michael J. LaCascia (Age 59)Chief Legal Officer Compensation: $565.5kMr. Saurabh Sewak Ph.D.Vice President of Corporate DevelopmentMr. Carlos Costa (Age 51)Chief People Officer 2 recent tradesMs. Fanny Cavalie (Age 46)Chief Strategy & Business Operations Officer More Insider Trading Tools from MarketBeat Related Companies ARS Pharmaceuticals Insider Trading Rocket Pharmaceuticals Insider Trading Avadel Pharmaceuticals Insider Trading Bicycle Therapeutics Insider Trading Collegium Pharmaceutical Insider Trading Septerna Insider Trading Zymeworks Insider Trading Bicara Therapeutics Insider Trading Gyre Therapeutics Insider Trading Poseida Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:FHTX) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Foghorn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FHTX Stock Alerts